SR Biotek, Inc.
KKRX:2702109,920.00
KRW
+120.00
(+1.22%)
ISIN
KR7270210008
Return %
Stock
S&P 500
1Y
-36.04
14.20
3Y
112.65
81.12
5Y
131.95
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Full Time Employees
- 41
- Sector
- Consumer non-durables
- Industry
- Tobacco
- Address
- Seongnam-si South Korea
- IPO Date
- Jun 15, 2017
- Website
- srbiotek.com
- Similar Companies
- Business
- SR Biotek, Inc. is a South Korea-based biotechnology and cosmeceutical company specializing in the research, development, manufacturing, and commercialization of bio-derived micro-needle skin delivery systems, specialized dermatological solutions, and functional cosmetic products. Founded in 2006 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company operates across the biotechnology, aesthetic medicine, and personal care industries. The company operates through two primary business divisions: Proprietary Brand Products and Original Equipment Manufacturing/Original Design Manufacturing (OEM/ODM) Services. The company's core product and service portfolio includes: Micro-Needle Peeling and Resurfacing Systems, marketed under proprietary brands such as Spicule-X, which utilize purified bio-silica spicules derived from sponges to facilitate transdermal drug and active ingredient delivery for intensive skin renewal, acne care, pore tightening, and wrinkle reduction; Functional Derma-Cosmetics, comprising high-concentration ampoules, peptide-infused lifting serums, epidermal growth factor (EGF) restorative creams, soothing post-peeling repair balms, and skin barrier regenerating lotions; Professional Aesthetic Solutions, featuring specialized clinic-grade peeling kits, meso-aesthetic solutions, calming hydrogel masks, and post-procedure recovery treatments distributed to dermatology clinics, aesthetic salons, and medical spas; Bio-Active Cosmetic Ingredients, supplying refined spicule micro-needle raw materials, customized peptide complexes, and fermented botanical compounds; and Comprehensive OEM/ODM Manufacturing Services, offering custom formulation engineering, clinical testing support, regulatory compliance documentation, packaging design, and full-scale manufacturing for domestic and international beauty brands. SR Biotek, Inc. distributes its products across domestic and international markets, maintaining commercial reach across South Korea, China, Japan, Southeast Asia, North America, and Europe. In recent strategic and operational developments, the company has expanded its production infrastructure with automated bio-spicule purification and formulation facilities to scale output for export markets. The company has expanded its global footprint by entering new distribution and private-label manufacturing agreements with international cosmetics brand aggregators in Asia and North America. Furthermore, the company has advanced its product portfolio through the rollout of next-generation bio-spicule formulations integrated with targeted anti-aging peptide complexes, alongside expanding its patent portfolio and clinical trial verifications for non-invasive transdermal cosmetic delivery systems.